Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature

Frank Behrens, Juan D Cañete, Ignazio Olivieri, Arno W van Kuijk, Neil McHugh, Bernard Combe

Research output: Contribution to journalArticle

38 Citations (Scopus)
141 Downloads (Pure)

Abstract

The aim of this study was to review the available evidence on TNF inhibitor monotherapy vs combination therapy with MTX in PsA.
Original languageEnglish
Pages (from-to)915-926
Number of pages12
JournalRheumatology
Volume54
Issue number5
Early online date27 Oct 2014
DOIs
Publication statusPublished - May 2015

Fingerprint Dive into the research topics of 'Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature'. Together they form a unique fingerprint.

  • Cite this